REQUEST A DEMO
Total
USD $0.00
Search more companies

Charles River Laboratories Hungary Kft. (Hungary)

Main Activities: Other Scientific and Technical Consulting Services
Full name: Charles River Laboratories Hungary Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

Charles River Laboratories Hungary Ltd. is part of Charles River Laboratories International. Business segments include preclinical research, laboratory animal breeding and pharmaceutical testing services. Geographic scope is Hungary with international research clients. Key assets include laboratory facilities and research infrastructure. Strategic focus is on drug discovery support and regulated laboratory services.

Headquarters
Szabadsagpuszta hrsz 028/1.
Veszprem; Veszprem; Postal Code: 8200

Contact Details: Purchase the Charles River Laboratories Hungary Kft. report to view the information.

Website: http://www.criver.com

Basic Information
Total Employees:
Purchase the Charles River Laboratories Hungary Kft. report to view the information.
Registered Capital:
Purchase the Charles River Laboratories Hungary Kft. report to view the information.
Financial Auditors:
Purchase the Charles River Laboratories Hungary Kft. report to view the information.
Incorporation Date:
October 01, 1989
Key Executives
Purchase this report to view the information.
Member of the Supervisory Board
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Charles River Laboratories Hungary Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-10.55%
Total operating revenue
-11.12%
Operating Profit/Loss (EBIT)
-21.98%
EBITDA
-18.6%
Net Profit/Loss for the Period
-5.82%
Total Assets
-3.8%
Total Equity
-3.01%
Operating Profit Margin (ROS)
-4.48%
Net Profit Margin
1.47%
Return on Equity (ROE)
-0.99%
Debt/Equity
-0.04%
Quick Ratio
0.09%
Cash Ratio
-1.54%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?